How long do hot flushes last? For most women, longer than they are told

The short answer women are rarely given: hot flushes and night sweats commonly last far longer than the year or two many expect. In the most detailed long-term study of the question, frequent symptoms persisted for a median of 7.4 years — and for more than four years after the final period [s1].

That figure comes from the Study of Women's Health Across the Nation (SWAN), a multiracial, multiethnic US study that followed 3,302 women across seven sites from February 1996 through April 2013, with a median of 13 study visits each [s1]. The duration analysis focused on the 1,449 women who reported frequent vasomotor symptoms, defined as hot flushes or night sweats on at least six of the previous 14 days [s1].

What the numbers say

The median total duration of frequent symptoms was 7.4 years [s1]. Among the 881 women who had an observable final menstrual period, the median persistence after that point — the part women least expect — was 4.5 years [s1].

Crucially, duration depended heavily on when symptoms started. Women who were premenopausal or in early perimenopause when they first reported frequent symptoms had the longest course: a median total duration exceeding 11.8 years, and 9.4 years of persistence after the final period [s1]. Women whose symptoms only began once they were already postmenopausal had the shortest, at a median of 3.4 years [s1]. In other words, early-starting hot flushes are not a sign they will pass quickly — often the opposite.

There were differences by group as well. Compared with women of other racial and ethnic backgrounds, African American women reported the longest total duration, a median of 10.1 years [s1]. Younger age, lower educational level, greater perceived stress and symptom sensitivity, and higher depressive and anxiety symptoms at the first report of hot flushes were also linked to longer-lasting symptoms [s1].

Why this matters for decisions

The reason the SWAN authors set out to measure duration at all is that it changes the calculus of treatment. As they put it, the expected duration "is important to women making decisions about possible treatments" [s1]. A symptom framed as lasting a few months invites waiting it out; a symptom that may run past seven years, and longer for some, is a different proposition. The authors concluded that clinicians should counsel women to expect frequent symptoms could last more than seven years, and longer for African American women [s1].

It is worth being clear about what this study is and is not. It is observational, so it describes the natural history of symptoms rather than testing any treatment, and the medians hide wide variation — some women have symptoms briefly, others far beyond the averages. The "7.4 years" is a midpoint, not a sentence.

The duration figure also matters for a symptom that is easy to underrate: night sweats. Because SWAN counted hot flushes and night sweats together as vasomotor symptoms, the multi-year course applies to sleep-disrupting nocturnal episodes as well as daytime flushing [s1]. For women whose main complaint is broken sleep rather than visible flushing, the same expectation-setting holds — this can be a years-long problem, and one that quietly erodes rest, mood and daytime function over that time.

What actually helps

For women who do want relief, the evidence base has broadened beyond hormones. Menopausal hormone therapy remains the most effective treatment for vasomotor symptoms, but it is not suitable or preferred for everyone. The North American Menopause Society's 2023 position statement on non-hormone therapies reviewed the alternatives and found reasonable evidence for specific options — including certain SSRI and SNRI antidepressants, gabapentin, oxybutynin, and cognitive behavioural therapy — while advising against a number of popular supplements and approaches that lack support [s2]. Newer non-hormonal drugs that target the brain's temperature-control pathway have since entered the picture as well.

None of that changes the core message of the SWAN data, which is about expectation-setting. The most useful thing many women can be told at the start of the transition is simply that this may last years, not months — because that single fact reframes whether to treat, when to seek help, and how to plan for a symptom that, for more than half of women, outlasts the periods it accompanies.

Sources

• [s1] JAMA Internal Medicine — https://doi.org/10.1001/jamainternmed.2014.8063
• [s2] Menopause — https://doi.org/10.1097/GME.0000000000002200